We are live on ! Find out more
BEAM icon

Beam Therapeutics
BEAM

224 hedge funds and large institutions have $2.6B invested in Beam Therapeutics in 2022 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 74 increasing their positions, 65 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

247% more call options, than puts

Call options by funds: $53.9M | Put options by funds: $15.5M

76% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 25

24% more capital invested

Capital invested by funds: $2.09B → $2.6B (+$509M)

14% more repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 65

9% more funds holding

Funds holding: 205 → 224 (+19)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

0.26% less ownership

Funds ownership: 77.81% → 77.55% (-0.26%)

Holders
224
Holders Change
+19
Holders Change %
+9.27%
% of All Funds
3.86%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
44
Increased
74
Reduced
65
Closed
25
Calls
$53.9M
Puts
$15.5M
Net Calls
+$38.4M
Net Calls Change
+$44.4M

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$52.9M
2
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
+$21.4M
3
EAM
Eventide Asset Management
Massachusetts
+$15.2M
4
HRCM
Hood River Capital Management
Florida
+$13.1M
5
NAMA
Nikko Asset Management Americas
New York
+$12.5M

Top Sellers

1
Temasek Holdings
Temasek Holdings
Singapore
-$62.3M
2
State Street
State Street
Massachusetts
-$44.1M
3
AIM
ARK Investment Management
Florida
-$17.2M
4
DTC
Deep Track Capital
Connecticut
-$14.3M
5
Millennium Management
Millennium Management
New York
-$13.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
GAA
126
Green Alpha Advisors
Colorado
$468K +$3.08K +54 +0.6%
PCM
127
Penserra Capital Management
California
$459K +$392K +6,863 +247%
AQR Capital Management
128
AQR Capital Management
Connecticut
$459K +$550K +9,641 New
Zurich Cantonal Bank
129
Zurich Cantonal Bank
Switzerland
$457K -$59.2K -1,038 -10%
Stifel Financial
130
Stifel Financial
Missouri
$457K +$547K +9,584 New
AWE
131
Avidian Wealth Enterprises
Texas
$448K +$188K +3,300 +54%
SEI Investments
132
SEI Investments
Pennsylvania
$440K +$526K +9,229 New
GCP
133
GSA Capital Partners
United Kingdom
$439K +$143K +2,510 +37%
VRS
134
Virginia Retirement Systems
Virginia
$405K +$485K +8,500 New
Janney Montgomery Scott
135
Janney Montgomery Scott
Pennsylvania
$396K -$251K -4,406 -35%
EFM
136
E Fund Management
China
$395K -$283K -4,954 -37%
UBS Group
137
UBS Group
Switzerland
$389K -$1.79M -31,393 -79%
PA
138
Profund Advisors
Maryland
$379K +$74K +1,297 +19%
SG Americas Securities
139
SG Americas Securities
New York
$370K -$1.16M -20,418 -72%
YIH
140
Y-Intercept (HK)
Hong Kong
$329K +$394K +6,911 New
Verition Fund Management
141
Verition Fund Management
Connecticut
$327K -$81.5K -1,429 -17%
US Bancorp
142
US Bancorp
Minnesota
$319K -$30.7K -539 -7%
KJHP
143
K.J. Harrison & Partners
Ontario, Canada
$310K -$570K -10,000 -61%
Public Employees Retirement Association of Colorado
144
Public Employees Retirement Association of Colorado
Colorado
$297K – – –
SO
145
STRS Ohio
Ohio
$281K +$160K +2,800 +90%
FM
146
Family Management
New York
$271K -$1.43K -25 -0.4%
HTHT
147
Hemenway Trust Hemenway Trust
New Hampshire
$271K +$324K +5,680 New
Envestnet Asset Management
148
Envestnet Asset Management
Illinois
$266K +$318K +5,580 New
KIA
149
Kraematon Investment Advisors
Massachusetts
$263K – – –
Cambridge Investment Research Advisors
150
Cambridge Investment Research Advisors
Iowa
$260K +$312K +5,461 New
4 5
6
7 8

BEAM Hedge Fund Activity: Q3 2022 in Review

224 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Beam Therapeutics (BEAM) for Q3 2022, worth a combined $2.6B — up 24% from $2.09B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new BEAM positions and 25 closed out — a net gain of 19 holders — while 74 added to existing stakes and 65 trimmed.

The largest buyer was Vanguard Group, adding an estimated $52.9M. The largest seller was Temasek Holdings, cutting an estimated $62.3M.

  • 224 institutional investors held Beam Therapeutics (BEAM) as of Q3 2022, up from 205 in Q2 2022.
  • Funds reported $2.6B of Beam Therapeutics stock for Q3 2022, up 24% quarter-over-quarter.
  • 44 funds opened new Beam Therapeutics positions in Q3 2022 and 25 closed out, a net change of +19 holders.
  • The largest Beam Therapeutics buyer in Q3 2022 was Vanguard Group, an estimated $52.9M added.
  • The largest Beam Therapeutics seller in Q3 2022 was Temasek Holdings, an estimated $62.3M sold.

Based on aggregated 13F filings for Q3 2022.